Three-year data from the largest FDA-reviewed prospective neuromodulation study of safety and effectiveness in drug-resistant focal ...

NeuroPace (NPCE) announced three-year effectiveness data from the Post-Approval Study, PAS, of the RNS System, which showed an 82% median ...

A recent paper published in National Science Review presents a multi-space alignment approach for cross-species and cross-modality electroencephalogram (EEG) based epileptic seizure detection. By ...

The uncontrolled thrashing raises their chances of getting hurt. Focal seizures are different; they start in one area on one side of the brain, so they may be less intense and usually last no more ...

A real-world study supports cenobamate as an effective option for patients with drug-resistant epilepsy even after multiple ...

1 in 3 patients did not require intracranial EEG monitoring ... data of the RNS System in adults with drug-resistant focal epilepsy from the PAS were submitted to the FDA in November 2024 ...

Seizure freedom with 42% of patients remaining seizure free for 6+ months. 1 in 3 patients did not require intracranial EEG monitoring.

Three-year data from the largest FDA-reviewed prospective neuromodulation study of safety and effectiveness in drug-resistant focal epilepsy1Long-term seizure reduction with a median reduction of 82% ...

1 in 3 patients did not require intracranial EEG monitoring. "We are committed to helping people ... The three-year safety and effectiveness data of the RNS System in adults with drug-resistant focal ...